Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech ...

Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over ...

Rival developers of Covid-19 jabs have faced off at the High Court in London as a weeks-long trial over life ... American competitor Pfizer and its German-partner BioNTech for alleged patent ...

We previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech Manufacturing GmbH, BioNTech US Inc. (collectively, ...

Pfizer and BioNTech attempted to parry Moderna’s legal challenge in Dec. 2022 by filing a countersuit, demanding a jury trial and refuting Moderna’s claims. In pushing back against Moderna’s ...

Representatives for Pfizer ... Trial and Appeal Board, which reconsiders the validity of patents issued by the office, as an alternative path to fend off infringement claims. Pfizer and BioNTech ...

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...

Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a ...

The lawsuit adds to a web of high-stakes U.S. court cases involving Pfizer, BioNTech and Moderna over patent royalties for technology used in their vaccines, including a case brought by Moderna ...

GSK said in the lawsuit , opens new tab that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the ...